Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Thyroid Eye Disease (TED) Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, a robust growth has been observed in the market size of thyroid eye disease (TED). The market, which is anticipated to escalate from $2.15 billion in 2024 to $2.29 billion in 2025, is expected to witness a compound annual growth rate (CAGR) of 6.7%. This growth has its roots in the rising incidence of thyroid disorders, and an expanded focus on patient-centered care. Additionally, burgeoning demand for aesthetic procedures, a growing prevalence of the condition, and an increased number of treatment choices for TED have significantly contributed to this market expansion.

The market size for thyroid eye disease (ted) is projected to witness substantial expansion in the upcoming years, with an estimation to reach$2.94 billion by 2029, experiencing a 6.4% compound annual growth rate (CAGR). This growth acceleration during the forecast time is primarily due to the rising occurrences of Graves’ disease, enhanced funding in various sectors, escalated health care expenditure, an upsurge in the use of thyroid hormone replacement therapy, and the increasing cases of thyroid disease. The forecast period will likely see key trends such as advancements in technology, broadening research and development initiatives, the introduction of new drugs, improvements in treatment alternatives, and cutting-edge surgical procedures.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp

What Are the Core Market Drivers Propelling Growth in the Thyroid Eye Disease (TED) Industry?

The escalating rate of thyroid-related disorders is anticipated to accelerate the expansion of the thyroid eye disease (TED) market. Thyroid maladies are health issues that interfere with the thyroid gland’s functionality, causing hormonal imbalances that manifest in conditions like hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. The rise in thyroid disorders can be attributed to factors such as increased intake of iodine, autoimmune diseases, genetic susceptibility, and heightened awareness resulting in superior diagnostic rates. Thyroid Eye Disease (TED) adds to the increase in thyroid disorder cases because it is a frequent and severe complication of Graves’ disease, thereby augmenting the total burden and knowledge of thyroid-related ailments. As an example, in May 2024, the Canadian Cancer Society, a community-focused, non-profit organization based in Canada, predicted that in 2024, around 6,600 new instances of thyroid cancer are likely to be identified in Canada, with an estimated 280 deaths projected. Consequently, the surge in thyroid disorders is fostering the growth of the thyroid eye disease (TED) market.

How Is the Thyroid Eye Disease (TED) Market Segmented?

The thyroid eye disease (ted)market covered in this report is segmented –

1) By Treatment Type: Medical; Surgical; Combination Of Medical And Surgical

2) By Disease Severity: Mild; Moderate; Severe

3) By Drug Type: Biologics; Small Molecules; Others Drug Type

4) By Route Of Administration: Oral; Intravenous; Subcutaneous

5) By End User: Hospitals; Clinics; Other End Users

Subsegments:

1) By Medical: Corticosteroids; Teprotumumab; Antithyroid Medications; Other Medical Treatments

2) By Surgical: Orbital Decompression Surgery; Eyelid Surgery; Strabismus Surgery

3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression; Combination of Teprotumumab and Eyelid Surgery; Other Combined Approaches

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21300&type=smp

Which Regions Are Driving the Next Phase of the Thyroid Eye Disease (TED) Market Growth?

North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (TED) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Thyroid Eye Disease (TED) Industry?

Leading companies in the thyroid eye disease (TED) market are concentrating on the development of pioneering products, including monoclonal antibody treatments, to generate more powerful and personalized therapies that alleviate inflammation, enhance proptosis, and improve overall patient results. Monoclonal antibody treatments involve the use of lab-created antibodies, which are designed to imitate the immune system’s ability to identify and neutralize specific pathogens or irregular cells. For example, back in September 2024, Amgen Inc., an American biotechnology firm, revealed that Japan’s Ministry of Health, Labour and Welfare (MHLW) had green-lighted TEPEZZA (teprotumumab), a remedy for active thyroid eye disease (TED), a unique and potentially sight-threatening autoimmune disorder. TEPEZZA is the singular FDA-approved treatment intentionally for TED, providing a focused therapy that aids in the reduction of inflammation, puffiness, and other crippling symptoms linked with the disease. This validation is specifically beneficial for patients in Japan, as it offers a fresh and effective approach to manage TED, a rare and advancing condition that produces distressing eye protrusion, vision issues, and ocular discomfort.

View the full report here:

https://www.thebusinessresearchcompany.com/report/thyroid-eye-disease-ted-global-market-report

How Is the Thyroid Eye Disease (TED) Market Defined and What Are Its Core Parameters?

Thyroid eye disease (TED), also known as Graves’ Orbitopathy, is an autoimmune condition characterized by inflammation and swelling of the tissues around the eyes, often associated with thyroid disorders. TED can cause symptoms such as bulging eyes, double vision, and eye pain.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21300

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model